Platelets, complement, and contact activation: partners in inflammation and thrombosis
Osama A Hamad1, Jennie Bäck, Per H Nilsson
1Dept of Immunology, Genetics and Pathology, Rudbeck Laboratory C5:3, Uppsala University, SE-751 85 Uppsala, Sweden. osama.hamad@igp.uu.se
Advances in Experimental Medicine and Biology
|September 28, 2011
Summary
Platelets mediate inflammation during thrombosis by interacting with complement and contact systems. Activated platelets release chondroitin sulfate A (CS-A), linking these systems and influencing leukocyte activation.
Area of Science:
- Immunology
- Hematology
- Biochemistry
Background:
- Platelet activation during thrombosis is linked to complement and contact system activation, driving inflammation.
- Understanding these interactions is crucial for managing thrombotic and inflammatory conditions.
Purpose of the Study:
- To review the complex interactions between activated platelets, the complement system, and the contact activation system in clotting blood.
- To elucidate the role of platelets as mediators and regulators of inflammation in thrombotic events.
Main Methods:
- Review of existing literature on platelet activation, complement pathways, and contact activation.
- Analysis of molecular interactions, including the role of chondroitin sulfate A (CS-A) and complement component C3.
- Examination of regulatory mechanisms involving membrane-bound complement regulators and antithrombin.
Main Results:
- Chondroitin sulfate A (CS-A) released from activated platelets mediates crosstalk with the complement system, activating it in the fluid phase and generating anaphylatoxins.
- Activated platelets bind C3(H(2)O) and recruit soluble complement regulators via exposed CS-A, while expressing membrane-bound regulators.
- Platelet activation triggers contact system enzymes, inhibited by antithrombin, differing from surface-induced activation.
Conclusions:
- Platelets are not only initiators of hemostasis but also key mediators and regulators of inflammation during thrombotic events.
- The interaction between platelets, complement, and contact systems highlights a critical inflammatory axis in thrombosis.
- Targeting these platelet-mediated inflammatory pathways may offer novel therapeutic strategies for thrombotic disorders.
Related Concept Videos
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:38Inflammation
Overview
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...